Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003663
Status:
WITHDRAWN
Last Update Posted:
2015-08-19
First Post:
1999-11-01
Brief Title:
Rituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent Non-Hodgkins Lymphoma
Sponsor:
Hoag Memorial Hospital Presbyterian
Organization:
Hoag Memorial Hospital Presbyterian
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| splenic marginal zone lymphoma | View |
| Waldenstrom macroglobulinemia | View |
| stage III grade 1 follicular lymphoma | View |
| stage III grade 2 follicular lymphoma | View |
| stage III grade 3 follicular lymphoma | View |
| stage IV grade 1 follicular lymphoma | View |
| stage IV grade 2 follicular lymphoma | View |
| stage IV grade 3 follicular lymphoma | View |
| recurrent grade 1 follicular lymphoma | View |
| recurrent grade 2 follicular lymphoma | View |
| recurrent grade 3 follicular lymphoma | View |
| recurrent marginal zone lymphoma | View |
| recurrent small lymphocytic lymphoma | View |
| stage III small lymphocytic lymphoma | View |
| stage III marginal zone lymphoma | View |
| stage IV small lymphocytic lymphoma | View |
| stage IV marginal zone lymphoma | View |
| extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue | View |
| nodal marginal zone B-cell lymphoma | View |